Save the date for the return of the 2nd CPLM Summit!

June 18 – 20, 2019

Boston, MA


REV•1 Engineering

REV•1 Engineering is a Development and Innovation (D&I) company specializing in complex medical devices. Our proprietary approach optimizes and aligns engineering, regulatory compliance, documentation and quality systems requirements to accelerate speed to revenue, from concept to commercialization. Over the past decade, we’ve developed more than 140 medical devices for more than 70 client companies, contributing in excess of $1 billion to client company valuation. Our D&I expertise extends to interventional cardiology, drug/device combination products, cardioablation, neuromodulation, neuro-ablation and in-vivo electroporation gene therapy delivery devices.